Persistent URL of this record https://hdl.handle.net/1887/119612
In Collections
This item can be found in the following collections:
![Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab
- All authors
- Langerak, A.W.; Ritgen, M.; Goede, V.; Robrecht, S.; Bahlo, J.; Fischer, K.; Steurer, M.; Trneny, M.; Mulligan, S.P.; Mey, U.J.M.; Trunzer, K.; Fingerle-Rowson, G.; Humphrey, K.; Stilgenbauer, S.; Bottcher, S.; Bruggemann, M.; Hallek, M.; Kneba, M.; Dongen, J.J.M. van
- Date
- 2019-01-31
- Journal
- Blood
- Volume
- 133
- Issue
- 5
- Pages
- 494 - 497